NCT01854567 - P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 23, 2016

Study Completion Date

May 5, 2017

Conditions

Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaHodgkin's Disease

Interventions

BIOLOGICAL

Infusion of one MPC expanded cord unit and one unexpanded cord unit

Infusion of one MPC expanded cord unit and one unexpanded cord unit.

BIOLOGICAL

Infusion of two unexpanded cord blood units.

Umbilical Cord Blood.

Trial Locations (9)

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell-New York Presbyterian Hospital, New York

Westchester Medical Center, Valhalla

University of Miami Health System Sylvester Comprehensive Cancer Center, Miami

Moffitt Cancer Center, Tampa

Case Western, Cleveland

MD Anderson Cancer Center, Houston

Texas Transplant Center at Methodist Healthcare System, San Antonio

Beth Israel Deaconess Medical Center, Boston